Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19

被引:8
作者
Alape-Giron, Alberto [1 ,2 ]
Moreira-Soto, Andres [3 ]
Arguedas, Mauricio [1 ]
Brenes, Hebleen [4 ]
Bujan, Willem [2 ,5 ]
Corrales-Aguilar, Eugenia [6 ]
Diaz, Cecilia [1 ,2 ]
Echeverri, Ann [5 ]
Flores-Diaz, Marietta [1 ]
Gomez, Aaron [1 ]
Hernandez, Andres [1 ]
Herrera, Maria [1 ]
Leon, Guillermo [1 ]
Macaya, Roman [5 ]
Molina-Mora, Jose Arturo [6 ]
Mora, Javier [6 ]
Narayanan, Aarthi [7 ]
Sanabria, Alfredo [5 ]
Sanchez, Andres [1 ]
Sanchez, Laura [1 ]
Segura, Alvaro [1 ]
Segura, Eduardo [1 ]
Solano, Daniela [1 ]
Soto, Claudio
Stynoski, Jennifer L. [1 ]
Vargas, Mariangela [1 ]
Villalta, Mauren [1 ]
Drexler, Jan Felix [3 ]
Gutierrez, Jose Maria [1 ]
机构
[1] Univ Costa Rica, Inst Clodomiro Picado, Sch Microbiol, San Pedro, Costa Rica
[2] Univ Costa Rica, Sch Med, San Pedro, Costa Rica
[3] Charite Med Univ Berlin, Inst Virol, Berlin, Germany
[4] Inst Costarricense Invest Ensenanza Nutr Salu, Minist Hlth, Cartago, Costa Rica
[5] Caja Costarricense Seguro Social, San Jose, Costa Rica
[6] Univ Costa Rica, Sch Microbiol, Res Ctr Trop Dis, San Pedro, Costa Rica
[7] George Mason Univ, Coll Sci, Natl Ctr Biodefense & Infect Dis, Fairfax, VA USA
关键词
heterologous antibodies; passive immunotherapy; COVID-19; SARS-CoV-2; hyperimmune polyclonal antibodies; convalescent plasma; monoclonal antibodies; ADVERSE-REACTIONS; ANTIVENOMS; F(AB')(2); VARIANTS; SAFETY;
D O I
10.3389/fmed.2021.743325
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:5
相关论文
共 40 条
  • [1] Randomised Controlled Double-Blind Non-Inferiority Trial of Two Antivenoms for Saw-Scaled or Carpet Viper (Echis ocellatus) Envenoming in Nigeria
    Abubakar, Isa S.
    Abubakar, Saidu B.
    Habib, Abdulrazaq G.
    Nasidi, Abdulsalam
    Durfa, Nandul
    Yusuf, Peter O.
    Larnyang, Solomon
    Garnvwa, John
    Sokomba, Elijah
    Salako, Lateef
    Theakston, R. David G.
    Juszczak, Ed
    Alder, Nicola
    Warrell, David A.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2010, 4 (07):
  • [2] Ainsworth S., 2020, Wellcome Open Res., V5, P115, DOI DOI 10.12688/WELLCOMEOPENRES.15990.1
  • [3] Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial
    Ali, Shaukat
    Uddin, Syed Muneeb
    Shalim, Elisha
    Sayeed, Muneeba Ahsan
    Anjum, Fatima
    Saleem, Farah
    Muhaymin, Sheikh Muhammad
    Ali, Ayesha
    Ali, Mir Rashid
    Ahmed, Iqra
    Mushtaq, Tehreem
    Khan, Sadaf
    Shahab, Faisal
    Luxmi, Shobha
    Kumar, Suneel
    Arain, Habiba
    Khan, Mujtaba
    Khan, Abdul Samad
    Mehmood, Hamid
    Rasheed, Abdur
    Jahangeer, Ashraf
    Baig, SaifUllah
    Quraishy, Saeed
    [J]. ECLINICALMEDICINE, 2021, 36
  • [4] Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma
    Ali, Shaukat
    Uddin, Syed M.
    Ali, Ayesha
    Anjum, Fatima
    Ali, Rashid
    Shalim, Elisha
    Khan, Mujtaba
    Ahmed, Iqra
    M Muhaymin, Sheikh
    Bukhari, Uzma
    Luxmi, Shobha
    Khan, Abdul S.
    Quraishy, Saeed
    [J]. IMMUNOTHERAPY, 2021, 13 (05) : 397 - 407
  • [5] COVID-19 Pandemic and Equal Access to Vaccines
    Bolcato, Matteo
    Rodriguez, Daniele
    Feola, Alessandro
    Di Mizio, Giulio
    Bonsignore, Alessandro
    Ciliberti, Rosagemma
    Tettamanti, Camilla
    Trabucco Aurilio, Marco
    Aprile, Anna
    [J]. VACCINES, 2021, 9 (06)
  • [6] Assessment of the viral safety of antivenoms fractionated from equine plasma
    Burnouf, T
    Griffiths, E
    Padilla, A
    Seddik, S
    Stephano, MA
    Gutiérrez, JM
    [J]. BIOLOGICALS, 2004, 32 (03) : 115 - 128
  • [7] The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
    Casadevall, Arturo
    Pirofski, Liise-Anne
    Joyner, Michael J.
    [J]. MBIO, 2021, 12 (02): : 1 - 13
  • [8] Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
    Chen, Rita E.
    Zhang, Xianwen
    Case, James Brett
    Winkler, Emma S.
    Liu, Yang
    VanBlargan, Laura A.
    Liu, Jianying
    Errico, John M.
    Xie, Xuping
    Suryadevara, Naveenchandra
    Gilchuk, Pavlo
    Zost, Seth J.
    Tahan, Stephen
    Droit, Lindsay
    Turner, Jackson S.
    Kim, Wooseob
    Schmitz, Aaron J.
    Thapa, Mahima
    Wang, David
    Boon, Adrianus C. M.
    Presti, Rachel M.
    O'Halloran, Jane A.
    Kim, Alfred H. J.
    Deepak, Parakkal
    Pinto, Dora
    Fremont, Daved H.
    Crowe, James E., Jr.
    Corti, Davide
    Virgin, Herbert W.
    Ellebedy, Ali H.
    Shi, Pei-Yong
    Diamond, Michael S.
    [J]. NATURE MEDICINE, 2021, 27 (04) : 717 - 726
  • [9] Cunha L. E., 2020, EQUINE HYPERIMMUNE G, DOI DOI 10.1101/2020.08.17.254375
  • [10] COVID-19 and Hyperimmune sera: A feasible plan B to fight against coronavirus
    da Costa, Camila B. P.
    Martins, Francislene J.
    da Cunha, Luis E. R.
    Ratcliffe, Norman A.
    de Paula, Rafael Cisne
    Castro, Helena C.
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 90